4 July 2016 - Deborah Wilkes
Download this NEWS EXTRA publication to find out how Sanofi expects its acquisition of Boehringer Ingelheim’s Consumer Health Care business to give it a stronger global platform for launching prescription-to-OTC switches and other OTC innovations.
This News Extra covers:
- Profitability expectations
- OTC switch opportunities, including Cialis
- Sanofi’s “unique” OTC business model
- Geographic presence
- Key brands in the combined business
- Acquisition plans
The publication includes comments from Vincent Warnery, senior vice-president of Sanofi’s Global Consumer Healthcare business unit.
It is available to purchase and download immediately from the OTCToolbox website. You can make sure your team is well informed through a Multiple User Licence or a Global Licence.
The News Extra is available free to people with an Annual Subscription to the OTCToolbox website (click here to find out more).
RAPID INSIGHTS MADE EASY
AVAILABLE TO DOWNLOAD IMMEDIATELY AS A PDF
See Payment Options box at the top of this page
For alternative payment options and delivery methods, or other questions, please send an email to email@example.com.